Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 286

1.

Contributions of Thyroid Hormone to Cancer Metastasis.

Mousa SA, Glinsky GV, Lin HY, Ashur-Fabian O, Hercbergs A, Keating KA, Davis PJ.

Biomedicines. 2018 Aug 22;6(3). pii: E89. doi: 10.3390/biomedicines6030089. Review.

2.

Protective Effects of Miswak (Salvadora persica) against Experimentally Induced Gastric Ulcers in Rats.

Lebda MA, El-Far AH, Noreldin AE, Elewa YHA, Al Jaouni SK, Mousa SA.

Oxid Med Cell Longev. 2018 Jul 9;2018:6703296. doi: 10.1155/2018/6703296. eCollection 2018.

3.

Chitosan-based nanoformulated (-)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis.

Chamcheu JC, Siddiqui IA, Adhami VM, Esnault S, Bharali DJ, Babatunde AS, Adame S, Massey RJ, Wood GS, Longley BJ, Mousa SA, Mukhtar H.

Int J Nanomedicine. 2018 Jul 20;13:4189-4206. doi: 10.2147/IJN.S165966. eCollection 2018.

4.

Tetraiodothyroacetic acid (tetrac), integrin αvβ3 and disabling of immune checkpoint defense.

Davis PJ, Mousa SA, Lin HY.

Future Med Chem. 2018 Jul 1;10(14):1637-1639. doi: 10.4155/fmc-2018-0123. Epub 2018 Jun 29. No abstract available.

5.

High Plasma Sphingosine 1-phosphate Levels Predict Osteoporotic Fractures in Postmenopausal Women: The Center of Excellence for Osteoporosis Research Study.

Ardawi MM, Rouzi AA, Al-Senani NS, Qari MH, Elsamanoudy AZ, Mousa SA.

J Bone Metab. 2018 May;25(2):87-98. doi: 10.11005/jbm.2018.25.2.87. Epub 2018 May 31.

6.

Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent.

Ayoub BM, Mowaka S, Safar MM, Ashoush N, Arafa MG, Michel HE, Tadros MM, Elmazar MM, Mousa SA.

Sci Rep. 2018 Jun 12;8(1):8959. doi: 10.1038/s41598-018-27395-0.

7.

Demonstration of the Receptor Site for Thyroid Hormone on Integrin αvβ3.

Lin HY, Mousa SA, Davis PJ.

Methods Mol Biol. 2018;1801:61-65. doi: 10.1007/978-1-4939-7902-8_7.

PMID:
29892817
8.

New Interfaces of Thyroid Hormone Actions With Blood Coagulation and Thrombosis.

Davis PJ, Mousa SA, Schechter GP.

Clin Appl Thromb Hemost. 2018 Oct;24(7):1014-1019. doi: 10.1177/1076029618774150. Epub 2018 May 9.

PMID:
29742907
9.

Status and future directions in the management of pancreatic cancer: potential impact of nanotechnology.

Sielaff CM, Mousa SA.

J Cancer Res Clin Oncol. 2018 Jul;144(7):1205-1217. doi: 10.1007/s00432-018-2651-3. Epub 2018 May 2. Review.

PMID:
29721665
10.

Activation of tumor cell integrin αvβ3 by radiation and reversal of activation by chemically modified tetraiodothyroacetic acid (tetrac).

Leith JT, Hercbergs A, Kenney S, Mousa SA, Davis PJ.

Endocr Res. 2018 Apr 3:1-5. doi: 10.1080/07435800.2018.1456550. [Epub ahead of print]

PMID:
29611723
11.

Date Palm (Phoenix dactylifera): Novel Findings and Future Directions for Food and Drug Discovery.

El-Far AH, Oyinloye BE, Sepehrimanesh M, Allah MAG, Reidah IA, Shaheen HM, Razeghian-Jahromi I, Alsenosy AEA, Noreldin AE, Al Jaouni SK, Mousa SA.

Curr Drug Discov Technol. 2018 Mar 19. doi: 10.2174/1570163815666180320111937. [Epub ahead of print]

PMID:
29557751
12.

Synthesis of new analogs of tetraiodothyroacetic acid (tetrac) as novel angiogenesis inhibitors for treatment of cancer.

Rajabi M, Yalcin M, Mousa SA.

Bioorg Med Chem Lett. 2018 Apr 15;28(7):1223-1227. doi: 10.1016/j.bmcl.2018.02.045. Epub 2018 Feb 26.

PMID:
29519736
13.

Taribavirin and 5-Fluorouracil-Loaded Pegylated-Lipid Nanoparticle Synthesis, p38 Docking, and Antiproliferative Effects on MCF-7 Breast Cancer.

Abd-Rabou AA, Bharali DJ, Mousa SA.

Pharm Res. 2018 Feb 27;35(4):76. doi: 10.1007/s11095-017-2283-3.

PMID:
29488022
14.

Thyroid Hormone in the Clinic and Breast Cancer.

Hercbergs A, Mousa SA, Leinung M, Lin HY, Davis PJ.

Horm Cancer. 2018 Jun;9(3):139-143. doi: 10.1007/s12672-018-0326-9. Epub 2018 Feb 13. Review.

15.

Nonthyroidal Illness Syndrome and Thyroid Hormone Actions at Integrin αvβ3.

Hercbergs A, Mousa SA, Davis PJ.

J Clin Endocrinol Metab. 2018 Apr 1;103(4):1291-1295. doi: 10.1210/jc.2017-01939.

PMID:
29409047
16.

Molecular Basis of Nongenomic Actions of Thyroid Hormone.

Davis PJ, Leonard JL, Lin HY, Leinung M, Mousa SA.

Vitam Horm. 2018;106:67-96. doi: 10.1016/bs.vh.2017.06.001. Epub 2017 Jul 8.

PMID:
29407448
17.

Lycopene Attenuates Tulathromycin and Diclofenac Sodium-Induced Cardiotoxicity in Mice.

Abdel-Daim MM, Eltaysh R, Hassan A, Mousa SA.

Int J Mol Sci. 2018 Jan 24;19(2). pii: E344. doi: 10.3390/ijms19020344.

18.

Tetrac downregulates β-catenin and HMGA2 to promote the effect of resveratrol in colon cancer.

Nana AW, Chin YT, Lin CY, Ho Y, Bennett JA, Shih YJ, Chen YR, Changou CA, Pedersen JZ, Incerpi S, Liu LF, Whang-Peng J, Fu E, Li WS, Mousa SA, Lin HY, Davis PJ.

Endocr Relat Cancer. 2018 Mar;25(3):279-293. doi: 10.1530/ERC-17-0450. Epub 2017 Dec 18.

PMID:
29255096
19.

Fluorinated Analog NMR s of Organosulfur Compounds from Garlic (Allium sativum): Synthesis, Chemistry and Anti-Angiogenesis and Antithrombotic Studies.

Block E, Bechand B, Gundala S, Vattekkatte A, Wang K, Mousa SS, Godugu K, Yalcin M, Mousa SA.

Molecules. 2017 Nov 28;22(12). pii: E2081. doi: 10.3390/molecules22122081.

20.

Recent advances in management of autosomal-dominant polycystic kidney disease.

Potts JW, Mousa SA.

Am J Health Syst Pharm. 2017 Dec 1;74(23):1959-1968. doi: 10.2146/ajhp160886. Review.

PMID:
29167138

Supplemental Content

Loading ...
Support Center